MicroMed DeBakey Trial Ready To Begin Following CMS Payment Change
This article was originally published in The Gray Sheet
Executive Summary
CMS' decision to reimburse axial flow left-ventricular assist devices at the same rate as positive displacement LVADs resulted from meetings between the agency and system developers and researchers, MicroMed says